LYNCHBURG, Va. (WSET) — This week starts on a wet note thanks to a tropical system in the Atlantic. We're anticipating little direct impact from this storm, but we'll get a lot of outlying moisture ...

Findings showed 56.5% of patients receiving ruxolitinib cream 1.5% achieved IGA-TS compared with 10.8% of those receiving placebo. The Food and Drug Administration (FDA) has approved Opzelura ® ...

DUBOIS, Pa (WJAC) — A busy Clearfield County intersection could soon see a major change. DuBois city officials are moving forward with plans for a possible roundabout at Beaver Drive and Division ...

Antifibrotic therapy improves survival in PF-ILD patients, but not universally in all PPF cases, highlighting PPF heterogeneity. The "despite management" criterion helps identify patients who benefit ...

Gene therapies for rare diseases are frequently developed then discarded by drug companies because they can’t afford to produce the treatment for more patients. Gene therapies for rare diseases are ...

Clopidogrel monotherapy is superior to aspirin monotherapy for prevention of major adverse cardiovascular or cerebrovascular events (MACCE) without increasing major bleeding risk and supports the use ...

Ruxolitinib cream was approved for moderate atopic dermatitis in non-immunocompromised patients aged 2 years and older. The phase 3 TRuE-AD3 study showed significant efficacy and safety in children ...

The purpose of TECC training is to teach how to respond to and care for patients under adverse conditions and threats. Topics included hemorrhage control, tourniquet applications, physical assessment ...

Copyright: © 2025 The Author(s). Published by Elsevier Ltd.

The woman recently started her career as a lawyer and wants to have her own space getty A woman doesn't know if she should take her next step and move out of her parents' home. The original poster (OP ...

Selumetinib is approved for pediatric patients aged 1 year and older with NF1 and symptomatic, inoperable PN, based on bridging studies and efficacy data. The SPRINT study showed a 74% partial ...